[HTML][HTML] History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
C Heidbreder, PJ Fudala, MK Greenwald - Drug and alcohol dependence …, 2023 - Elsevier
Buprenorphine-based medications were first approved by the United States Food and Drug
Administration in 2002 for the treatment of opioid dependence, or opioid use disorder (OUD) …
Administration in 2002 for the treatment of opioid dependence, or opioid use disorder (OUD) …
Long‐term recovery from opioid use disorder: recovery subgroups, transition states and their association with substance use, treatment and quality of life
Abstract Background and Aims Limited information exists regarding individual subgroups of
recovery from opioid use disorder (OUD) following treatment and how these subgroups may …
recovery from opioid use disorder (OUD) following treatment and how these subgroups may …
Effectiveness of long-acting buprenorphine–A systematic review
J McMaster, H Abeysundera - Australasian Psychiatry, 2024 - journals.sagepub.com
Objective To analyse the evidence of the effectiveness of long-acting injection
buprenorphine (LAI-B) in the management of opioid use disorder (OUD). Method Databases …
buprenorphine (LAI-B) in the management of opioid use disorder (OUD). Method Databases …
The Phenotype of Recovery X: Associations between delay discounting, regulatory flexibility, and remission from substance use disorder
Introduction Delay discounting (DD) and self-regulation are important predictors of
substance use disorder (SUD) outcomes. Further, regulatory flexibility (RF; ie, selecting …
substance use disorder (SUD) outcomes. Further, regulatory flexibility (RF; ie, selecting …
[HTML][HTML] Pain severity contributes to worse outcomes in opioid use disorder recovery than pain status
Background Opioid use disorder (OUD) continues to pose a significant challenge to public
health in the United States. Chronic pain and OUD are highly comorbid conditions, yet few …
health in the United States. Chronic pain and OUD are highly comorbid conditions, yet few …
Pain Medication Use Two Years After Adolescent Idiopathic Scoliosis Fusion Surgery
Study Design. Observational case control. Objective. The objective of this study was to
evaluate the prevalence of opioid use two years after surgical correction of adolescent …
evaluate the prevalence of opioid use two years after surgical correction of adolescent …
The phenotype of recovery XII: A reinforcer pathology perspective on associations between delay discounting and pain catastrophizing in substance use disorder …
Background Substance use disorder (SUD) and pain are highly comorbid conditions and
several pain indices (eg, pain intensity) are associated with an increased risk of relapse …
several pain indices (eg, pain intensity) are associated with an increased risk of relapse …
Relationship between Depression and Stress on Accessing Recovery Capital among Individuals with Opioid Use Disorder
D Luciano - 2025 - search.proquest.com
This study addresses the critical need to understand how mental health challenges and
external stressors affect long-term recovery from an Opioid Use Disorder (OUD). Grounded …
external stressors affect long-term recovery from an Opioid Use Disorder (OUD). Grounded …
Bayesian Factor Models for Clustering and Spatiotemporal Analysis
H Shin - 2024 - vtechworks.lib.vt.edu
Multivariate data is prevalent in modern applications, yet it often presents significant
analytical challenges. Factor models can offer an effective tool to address issues associated …
analytical challenges. Factor models can offer an effective tool to address issues associated …
A Review of Community-Based Interventions and Educational Initiatives for Overdose Prevention & Treatment for Opioid Use Disorder in the United States
S Kulkarni - 2024 - repositories.lib.utexas.edu
Opioid use disorder (OUD) is a major health challenge facing the United States today, with
80,411 people dying from opioid-involved overdoses in 2021, accounting for 75.4% of …
80,411 people dying from opioid-involved overdoses in 2021, accounting for 75.4% of …